BioSpace News Archive

PharmOptima, a member of Genesis Drug Discovery & Development, the contract research organization arm of Genesis Biotechnology Group®, has announced the appointment of Anthony Rohr as its new Chief Executive Officer.

Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that company management will be presenting at the 2020 Wedbush PacGrow Healthcare Virtual Conference. The presentation will take place on Tuesday, August 11, 2020 at 2:20 PM EDT. A live webcast of each presentation will be available on the

Tonix Pharmaceuticals Holding Corp. a clinical-stage biopharmaceutical company, announced that it has regained compliance with the minimum bid price requirement for continued listing on the NASDAQ Global Market.

Ii-Key-SARS-CoV-2 vaccine progress Ii-Key-H1 Swine flu vaccine opportunity SEC Filings and plans for listing on a national exchange MIRAMAR, Fla., Aug. 04, 2020 (GLOBE NEWSWIRE) -- NuGenerex Immuno-Oncology ( NGIO ) today announced that it will hold an investor conference call on Thursday, August 27th at 9:00 am. During the call, NGIO CEO Joe Moscato will discuss the company’s efforts to develop a vaccine for the COVID-19 pandemic, and the use of the Ii-Key technology as a platform for de

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will report its financial results for the second quarter ended June 30, 2020 on Thursday, August 6, 2020, after the close of the U.S. financial markets. The announcement will be followed by a conference call and webcast with the investment community on Friday, August 7, 2020, at 9 a.m. ET. Participating on the call from Y-mAbs will be Thomas Gad, Founder, Ch

Todos Medical Ltd., an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, announced that it has appointed Jorge Leon, Ph.D. as consulting Chief Medical and Scientific Officer for Infectious Disease and Oncology.

RedHawk Holdings Corp. announced it has launched a new website for its SANDD line of products the week of July 26, 2020 to simplify online purchases.

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced the pricing of an underwritten public offering of 476,187 shares of its common stock at a price to the

Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has reached an agreement to be acquired by R. & D. Biocogency Laboratories Inc. Ltd (“Biocogency”). Under the agreed terms, Bio-cogency will acquire majority control of Rafarma Pharmaceuticals Inc. upon completion of Biocogency’s transition to GAAP reporting standards and finalization of acquisition agreements. For Biocogency, this acquisition will be an oppor

The acquisition expands Lubrizol’s 3D printing design, prototyping, printing and post-processing capabilities